Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Oct 1;156(4):1000-9.
doi: 10.1084/jem.156.4.1000.

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor

D I Beller et al. J Exp Med. .

Abstract

Anti-Mac-1 (M1/70), a rat monoclonal antibody that reacts with mouse and human macrophages, polymorphonuclear leukocytes (PMNL), and natural killer cells, selectively inhibited complement receptor-mediated rosetting by murine macrophages and human PMNL. Preincubation of macrophages with anti-Mac-1 inhibited formation of rosettes with sheep erythrocytes bearing IgM antibody and murine C3 fragments. No inhibition was observed when other monoclonal antibodies that react with macrophages (such as anti-Ly5, anti-H-2, or anti-pan-leukocyte) were tested at 10-fold higher concentrations. Anti-Mac-1 did not affect macrophage Fc receptor-mediated rosetting. Erythrocytes bearing homogeneous human C3 fragments C3b (EC3b) or C3bi (EC3bi) were used to test the specificity of the murine macrophage and human PMNL complement receptor inhibited by anti-Mac-1. In both cases, anti-Mac-1 inhibited CR3-mediated rosetting of EC3bi but not CR1-dependent rosetting of EC3b. The results show that Mac-1 is either identical to CR3 or closely associated with CR3 function. This is one of the first cases in which a monoclonal antibody-defined differentiation antigen has been associated with a specific cell surface function.

PubMed Disclaimer

References

    1. J Immunol Methods. 1974 Aug;5(3):249-52 - PubMed
    1. J Exp Med. 1977 Nov 1;146(5):1461-6 - PubMed
    1. Curr Top Microbiol Immunol. 1978;81:115-20 - PubMed
    1. Eur J Immunol. 1979 Apr;9(4):301-6 - PubMed
    1. J Exp Med. 1980 Jul 1;152(1):20-30 - PubMed

Publication types